References

 
1. Precursors to malignant melanoma. Consensus Conference. JAMA 1984;251:1864–1866.
 
2. Precursors to malignant melanoma. National Institutes of Health Consensus Development Conference Statement, Oct. 24–26, 1983. J Am Acad Dermatol 1984;10(4):683–688.
 
3. National Institutes of Health Consensus Development Conference: Precursors to malignant melanoma. Am J Dermatopathol 1984;6(suppl):169–174.
 
4. National Institutes of Health Consensus Development Conference: Diagnosis and treatment of early melanoma. JAMA 1992;268(10):1314–1319.
 
5. National Institutes of Health Consensus Development Conference Statement on Diagnosis and Treatment of Early Melanoma, January 27–29, 1992. Am J Dermatopathol 1993; 15(1):34–43.
 
6. Lynch HT, Fusaro RM, Lynch JF. The NIH Consensus Report on "Precursors to Malignant Melanoma": A different perspective. Am J Dermatopathol 1984;6(suppl):177–179.   
 
7. National Institutes of Health Consensus Report on Precursors to Malignant Melanoma: A difference in opinion. JAMA 1984;252(20):2872–2873.
 
8. Ackerman AB. Critical commentary on statements in "Precursors to Malignant Melanoma." Am J Dermatopathol 1984;6(suppl):181–183.   
 
9. Ackerman AB. Critique of definitions about melanocytic proliferations formulated by an NIH Panel. Am J Dermatopathol 1992;14(3):238–244.   
 
10. Ackerman AB. A critique of an NIH Consensus Development Conference about "Early" Melanoma. Am J Dermatopathol 1993;15(1):52–58.   
 
11. Elder DE, Clark WH Jr, Elenitsas R, et al. The early and intermediate precursor lesions of tumor progression in the melanocytic system: Common acquired nevi and atypical (dysplastic) nevi. Semin Diagn Pathol 1993;10(1):18–35.   
 
12. Clark WH Jr, Reimer RR, Greene MH, et al: Origin of familial malignant melanomas from heritable melanocytic lesions: "The B-K mole syndrome." Arch Dermatol 1978; 114(5):732–738.   
 
13. Elder DE, Goldman LI, Goldman SC, et al. Dysplastic nevus syndrome: A phenotypic association of sporadic cutaneous melanoma. Cancer 1980;46(8):1787–1794.   
 
14. Elder DE, Greene MH, Guerry D IV, et al. The dysplastic nevus syndrome: Our definition. Am J Dermatopathol 1982;4(5):455–460.   
 
15. Friedman RJ, Rigel DS, Kopf AW. Early detection of malignant melanoma. CA 1985;35:130–151.   
 
16. McBride A, Rivers JK, Kopf AW, et al. Clinical features of dysplastic nevi. Dermatol Clin 1991;9:717–722.   
 
17. Elder DE, Greene MH, Bondi EE, Clark WH Jr. Acquired melanocytic nevi and melanoma: The Dysplastic Nevus Syndrome. In Ackerman AB, ed. Pathology of Malignant Melanoma. New York: Masson, 1981:185–215.
 
18. Clark WH Jr, Elder DE, Guerry D IV, et al. Study of tumor progression. The precursor lesions of superficial spreading and nodular melanoma. Hum Pathol 1984;15(12):1147–1165.   
 
19. Greene MH, Clark WH Jr, Tucker MA, et al. Precursor naevi in cutaneous malignant melanoma: A proposed nomenclature [letter]. Lancet 1980;2(8202):1024.   
 
20. Piepkorn M, Meyer LJ, Goldgar D, et al. Zone JJ. The dysplastic melanocytic nevus: A prevalent lesion that correlates poorly with clinical phenotype. JAAD 1989;20(3):407–415.   
 
21. Kraemer KH, Greene MH, Tarone R, et al. Dysplastic nevi and cutaneous melanoma risk [letter]. Lancet 1983;2(8358): 1076–1077.   
 
22. Lynch HT, Frichot BC III, Lynch JF. Familial atypical mole-melanoma syndrome. J Med Genet 1978;15:352–356.   
 
23. Kopf AW, Friedman RJ, Rigel DS. Atypical mole syndrome. J An Acad Dermatol 1990;22(1):117–118.